Us2.ca vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Us2.ca
by Us2.ai
VS
Eko Low Ejection Fraction Tool (ELEFT)
by Eko Health

AI Verdict

Tool A (Us2.ai) is designed for comprehensive, automated analysis of echocardiograms, providing detailed diagnostic reports for various cardiac conditions. Tool B (Eko Low Ejection Fraction Tool) serves as a non-invasive screening tool for early detection of low ejection fraction using digital stethoscope data. While both address cardiac health, Us2.ai focuses on advanced imaging diagnostics, whereas ELEFT targets broader, earlier identification of heart failure risk in routine exams.

Choose Us2.ca if…

Choose Us2.ai if your cardiology department or imaging center requires fully automated, comprehensive echocardiography analysis to generate detailed, structured cardiac reports in seconds. This tool is ideal for enhancing diagnostic accuracy and workflow efficiency by integrating with existing ultrasound devices and EMR systems for in-depth cardiac structural and functional parameter assessment.

View Us2.ca →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your practice needs a rapid, non-invasive screening tool for the early detection of low ejection fraction during routine physical exams. This is best suited for primary care clinicians or general practitioners aiming to quickly identify patients at risk of heart failure using an AI algorithm integrated with Eko digital stethoscopes.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Us2.ca Eko Low Ejection Fraction Tool (ELEFT)
Deployment Vendor-neutral across GE, Philips, Siemens, Canon and handheld POCUS. Unknown
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Us2.ca Eko Low Ejection Fraction Tool (ELEFT)
Name Us2.ca Eko Low Ejection Fraction Tool (ELEFT)
Company Eko.Ai Pte Ltd. D/B/A Us2.Ai Eko Health
Description FDA-cleared and CE-marked AI platform that fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports in seconds to enhance diagnostic accuracy and workflow efficiency. FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Primary Function Fully automated echocardiography analysis AI-powered low ejection fraction detection
Integration Ultrasound devices, PACS, CVIS, and EMR Eko digital stethoscopes
Specialties Cardiology, Radiology Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Us2.ca and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Us2.ai fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports in seconds to enhance diagnostic accuracy and workflow efficiency. In contrast, the Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Us2.ai requires echocardiography data for its analysis, providing comprehensive cardiac structural and functional parameters, including 2D, Doppler, M-mode, and strain imaging. ELEFT analyzes ECG and heart sound recordings captured by integrated FDA-cleared Eko digital stethoscopes.
Us2.ai offers AI-powered disease detection for conditions such as Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, and Pulmonary Hypertension, along with guideline-based measurements. ELEFT is specifically designed to aid in the early identification of low ejection fraction (LVEF u2264 40%), indicating heart failure risk.
Us2.ai is designed for integration with ultrasound devices, PACS, CVIS, and EMR systems for seamless echocardiography analysis and structured report delivery. ELEFT integrates with Eko digital stethoscopes and is part of the SENSORAu2122 Cardiac Early Detection Platform, aiding clinicians during routine physical exams.
Us2.ai is primarily designed for Cardiology and Radiology specialties, focusing on advanced echocardiography analysis and reporting. ELEFT supports Cardiology, Family Medicine, and Internal Medicine, serving as a non-invasive screening tool for heart failure risk.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Us2.ca or Eko Low Ejection Fraction Tool (ELEFT)

Backers

Who funded each tool's parent company.

Eko Low Ejection Fraction Tool (ELEFT)

AI Tool Finder
AI-powered search. Results may not be comprehensive.